All abstracts will be peer-reviewed by the ASCO Plenary Series Review Committee and evaluated on the following criteria: 

  • Strength of Science: Does the research address an important and novel question?
  • Research Design: Are the eligibility criteria, study endpoints, and planned analysis well defined in this abstract?
  • Relevance: Are the results practice-changing? Will they have a clinical impact and be of broad interest to the ASCO community?

Abstracts of superior quality will be selected for oral presentation and for publication in a supplement to the Journal of Clinical Oncology. The oral presentation will be given by the first author on the corresponding ASCO Presentation Date. Each abstract presentation will be accompanied by a discussant presentation then followed by a live Question and Answer. For more detailed information, please visit the full Program. 

First authors will be invited to participate in a subsequent ASCO Annual Meeting session (exact presentation format to be determined). First authors will also be encouraged to submit their full manuscript for rapid review with the JCO.